162 related articles for article (PubMed ID: 31258862)
1. Low voltage criteria EKG as a harbinger of systemic disease.
Garrahy I; Forman D; Swierczynski S
J Community Hosp Intern Med Perspect; 2019; 9(3):226-229. PubMed ID: 31258862
[TBL] [Abstract][Full Text] [Related]
2. Light chain cardiac amyloidosis - a rare cause of heart failure in a young adult.
Domingues K; Saraiva M; Marta L; Monteiro I; Leal M
Rev Assoc Med Bras (1992); 2018 Sep; 64(9):787-790. PubMed ID: 30672998
[TBL] [Abstract][Full Text] [Related]
3. [Renal disorders associated with monoclonal gammopathies: diagnostic and therapeutic progress].
Bridoux F; Delbes S; Sirac C; Pourreau F; Puyade M; Desport E; Jaccard A; Fermand JP; Touchard G
Presse Med; 2012 Mar; 41(3 Pt 1):276-89. PubMed ID: 22244725
[TBL] [Abstract][Full Text] [Related]
4. AL type cardiac amyloidosis: a devastating fatal disease.
Nasrullah A; Javed A; Jayakrishnan TT; Brumbaugh A; Sandhu A; Hardman B
J Community Hosp Intern Med Perspect; 2021; 11(3):407-412. PubMed ID: 34234917
[TBL] [Abstract][Full Text] [Related]
5. Lingual liability: macroglossia and dyspnoea as the harbinger of systemic AL (light-chain) cardiac amyloidosis.
Williams MU; Murphy CE; Gore RS; Fentanes E
BMJ Case Rep; 2018 Dec; 11(1):. PubMed ID: 30580294
[TBL] [Abstract][Full Text] [Related]
6. A patient with AL amyloidosis with negative free light chain results.
Milani P; Valentini V; Ferraro G; Basset M; Russo F; Foli A; Palladini G; Merlini G
Clin Chem Lab Med; 2016 Jun; 54(6):1035-7. PubMed ID: 26677890
[TBL] [Abstract][Full Text] [Related]
7. Unusual Case of Nephrotic Syndrome From Light Chain Amyloidosis in a 37-Year-Old Patient.
Salameh OK; Darok MC; Kane JA; Abendroth C; Trivedi N
Cureus; 2021 Sep; 13(9):e18120. PubMed ID: 34692330
[TBL] [Abstract][Full Text] [Related]
8. Abrupt Onset of Refractory Heart Failure Associated With Light-Chain Amyloidosis in Hypertrophic Cardiomyopathy.
Tomberli B; Cappelli F; Perfetto F; Olivotto I
JAMA Cardiol; 2017 Jan; 2(1):94-97. PubMed ID: 27806176
[TBL] [Abstract][Full Text] [Related]
9. [Complete remission of nephrotic syndrome and improvement of renal function in a patient with light chain deposition disease following high dose chemotherapy with transplantation of autologous haematopoietic stem cells. A case study and review of literature].
Adam Z; Krejcí M; Pour L; Stepánková S; Cermáková Z; Voska L; Teplan V; Krivanová A; Hájek R; Mayer J
Vnitr Lek; 2009 Nov; 55(11):1089-96. PubMed ID: 20017442
[TBL] [Abstract][Full Text] [Related]
10. The clinicopathological spectrum of renal amyloidosis.
Hsu JY; Shu KH; Chan LP; Lu YS; Cheng CH; Sheu SS; Lian JD
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Oct; 54(4):230-9. PubMed ID: 7982133
[TBL] [Abstract][Full Text] [Related]
11. Extracorporeal membrane oxygenation as bridge-to-decision in acute heart failure due to systemic light-chain amyloidosis.
Mancio Silva J; Fontes-Carvalho R; Valente D; Almeida C; Cruz AJ; Tente D; Coelho H; Oliveira M; Albuquerque A; Ribeiro VG
Am J Case Rep; 2015 Mar; 16():174-81. PubMed ID: 25803181
[TBL] [Abstract][Full Text] [Related]
12. Development of Renal Failure without Proteinuria in a Patient with Monoclonal Gammopathy of Undetermined Significance: An Unusual Presentation of AL Kappa Amyloidosis.
Sun Y; Sandhu A; Gabaldon D; Danaraj J; Servilla KS; Tzamaloukas AH
Case Rep Nephrol; 2012; 2012():573650. PubMed ID: 24555136
[TBL] [Abstract][Full Text] [Related]
13. Primary systemic amyloidosis.
Comenzo RL
Curr Treat Options Oncol; 2000 Apr; 1(1):83-9. PubMed ID: 12057064
[TBL] [Abstract][Full Text] [Related]
14. [An unusual cause of hepatorenal symptoms].
Frank H; Krammer M; Fierlbeck W; Riess R; Geiger H
Med Klin (Munich); 1999 May; 94(5):274-8. PubMed ID: 10408189
[TBL] [Abstract][Full Text] [Related]
15. Paradoxical Left Ventricular Hypertrophy by Echocardiogram and Low Voltage ECG: A Key Clue in the Diagnostic Workup of Two Distinct Presentations of Cardiac AL Amyloidosis.
Tolu-Akinnawo O; Oyeleye K; Thayer T
Cureus; 2023 May; 15(5):e39143. PubMed ID: 37216130
[TBL] [Abstract][Full Text] [Related]
16. Amyloidosis: review of 236 cases.
Kyle RA; Bayrd ED
Medicine (Baltimore); 1975 Jul; 54(4):271-99. PubMed ID: 1152671
[TBL] [Abstract][Full Text] [Related]
17. Facial Paralysis as Initial Manifestation of Light-chain Amyloidosis.
Martins AM; Ferreira FS; Leite IM; Fonseca M; Victorino R
Cureus; 2019 Aug; 11(8):e5521. PubMed ID: 31687296
[TBL] [Abstract][Full Text] [Related]
18. Resolution of primary amyloidosis by melphalan and prednisolone: a case report.
Nakayama M; Kashiwagi M; Katafuchi R; Hori K; Hayashi S; Fujimi S
Clin Nephrol; 2005 Mar; 63(3):215-20. PubMed ID: 15786823
[TBL] [Abstract][Full Text] [Related]
19. Immunoglobulin light chain amyloidosis: 2018 Update on diagnosis, prognosis, and treatment.
Gertz MA
Am J Hematol; 2018 Sep; 93(9):1169-1180. PubMed ID: 30040145
[TBL] [Abstract][Full Text] [Related]
20. kappa/lambda index for confirming urinary free light chain in amyloidosis AL and other plasma cell dyscrasias.
Levinson SS
Clin Chem; 1991 Jun; 37(6):1122-6. PubMed ID: 1904799
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
